Kawasaki disease

Pediatrics in Review

Volumn 34, Issue 4, 2013, Pages 151-162

  Son, Mary Beth F ^a   Newburger, Jane W ^b  

^a NATIONAL UNIVERSITY HOSPITAL   (Singapore)

^b BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA 1 ANTITRYPSIN; C REACTIVE PROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IMMUNOGLOBULIN; INOSITOL TRISPHOSPHATE 3 KINASE; LOW MOLECULAR WEIGHT HEPARIN; MYELOID DIFFERENTIATION FACTOR 88; TRANSCRIPTION FACTOR NFAT; WARFARIN;

ABDOMINAL PAIN; ADAPTIVE IMMUNITY; ANEMIA; ANEURYSM; ARTHRALGIA; ARTHRITIS; ARTICLE; ASEPTIC MENINGITIS; CD8+ T LYMPHOCYTE; CHILDHOOD DISEASE; DIARRHEA; DIFFERENTIAL DIAGNOSIS; DRUG MEGADOSE; ECHOCARDIOGRAPHY; ERYTHROCYTE SEDIMENTATION RATE; FACIAL NERVE PARALYSIS; HOSPITALIZATION; HUMAN; HYPOALBUMINEMIA; INCIDENCE; INNATE IMMUNITY; IRRITABILITY; LEUKOCYTE COUNT; LEUKOCYTOSIS; LIVER FAILURE; LUNG NODULE; MUCOCUTANEOUS LYMPH NODE SYNDROME; PERCEPTION DEAFNESS; PLEOCYTOSIS; PLEURA EFFUSION; PROGNOSIS; RASH; RAYNAUD PHENOMENON; REGULATORY T LYMPHOCYTE; SCROTAL SWELLING; SINGLE NUCLEOTIDE POLYMORPHISM; THROMBOCYTOSIS; URETHRITIS; VOMITING; YERSINIA PSEUDOTUBERCULOSIS;

CHILD, PRESCHOOL; DIAGNOSIS, DIFFERENTIAL; FEMALE; FEVER; HUMANS; MUCOCUTANEOUS LYMPH NODE SYNDROME;

EID: 84877286386     PISSN: 01919601     EISSN: 15263347     Source Type: Journal    
DOI: 10.1542/pir.34-4-151     Document Type: Article

References (21)

1. Kawasaki T. Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children [in Japanese]. Arerugi. 1967;16(3):178-222
2. Kobayashi T, Inoue Y, Takeuchi K, et al. Prediction of intravenous immunoglobulin unresponsiveness in patients with Kawasaki disease. Circulation. 2006;113(22):2606-2612 (Pubitemid 43948009)
3. Takahashi K, Oharaseki T, Naoe S, et al. Neutrophilic involvement in the damage to coronary arteries in acute stage of Kawasaki disease. Pediatr Int. 2005;47(3):305-310 (Pubitemid 40827508)
4. Rosenkranz ME, Schulte DJ, Agle LM, et al. TLR2 and MyD88 contribute to Lactobacillus casei extract-induced focal coronary arteritis in a mouse model of Kawasaki disease. Circulation. 2005; 112(19):2966-2973 (Pubitemid 41612299)
5. Onoyama S, Ihara K, Yamaguchi Y, et al. Genetic susceptibility to Kawasaki disease: analysis of pattern recognition receptor genes. Hum Immunol. 2012;73(6):654-660
6. Popper SJ, Shimizu C, Shike H, et al. Gene-expression patterns reveal underlying biological processes in Kawasaki disease. Genome Biol. 2007;8(12):R261
7. Onouchi Y, Gunji T, Burns JC, et al. ITPKC functional polymorphism associated with Kawasaki disease susceptibility and formation of coronary artery aneurysms. Nat Genet. 2008;40(1):35-42
8. Schulte DJ, Yilmaz A, Shimada K, et al. Involvement of innate and adaptive immunity in a murine model of coronary arteritis mimicking Kawasaki disease. J Immunol. 2009;183(8):5311-5318
9. Newburger JW, Takahashi M, Gerber MA, et al Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease; Council on Cardiovascular Disease in the Young; American Heart Association; American Academy of Pediatrics. Diagnosis, treatment, and longterm management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation. 2004;110 (17):2747-2771 (Pubitemid 39453026)
10. Yellen ES, Gauvreau K, Takahashi M, et al. Performance of 2004 American Heart Association recommendations for treatment of Kawasaki disease. Pediatrics. 2010;125(2). Available at: www.pediatrics.org/cgi/content/full/125/2/e234
11. Benseler SM, McCrindle BW, Silverman ED, Tyrrell PN, Wong J, Yeung RS. Infections and Kawasaki disease: implications for coronary artery outcome. Pediatrics. 2005;116(6). Available at: www.pediatrics.org/cgi/content/full/116/ 6/e760
12. Shike H, Kanegaye JT, Best BM, Pancheri J, Burns JC. Pyuria associated with acute Kawasaki disease and fever from other causes. Pediatr Infect Dis J. 2009;28(5):440-443
13. McCrindle BW, Li JS, Minich LL, et al Pediatric Heart Network Investigators. Coronary artery involvement in children with Kawasaki disease: risk factors from analysis of serial normalized measurements. Circulation. 2007;116(2):174-179 (Pubitemid 47057523)
14. Kobayashi T, Saji T, Otani T, et al; RAISE study group investigators. Efficacy of immunoglobulin plus prednisolone for prevention of coronary artery abnormalities in severe Kawasaki disease (RAISE study): a randomised, open-label, blinded-endpoints trial. Lancet. 2012;379(9826):1613-1620
15. Durongpisitkul K, Gururaj VJ, Park JM, Martin CF. The prevention of coronary artery aneurysm in Kawasaki disease: a metaanalysis on the efficacy of aspirin and immunoglobulin treatment. Pediatrics. 1995;96(6):1057-1061
16. American Academy of Pediatrics. Kawasaki disease. In: Pickering LK, ed. Red Book: 2012. Report of the Committee on Infectious Diseases. 29th ed. Elk Grove Village, IL: American Academy of Pediatrics; 2012:454-460.
17. Hamaoka A, Hamaoka K, Yahata T, et al. Effects of HMG-CoA reductase inhibitors on continuous post-inflammatory vascular remodeling late after Kawasaki disease. J Cardiol. 2010;56(2): 245-253
18. Suda K, Iemura M, Nishiono H, et al. Long-term prognosis of patients with Kawasaki disease complicated by giant coronary aneurysms: a single-institution experience. Circulation. 2011;123 (17):1836-1842
19. Newburger JW, Takahashi M, Beiser AS, et al. A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome. N Engl J Med. 1991;324(23):1633-1639
20. Newburger JW, Sleeper LA, McCrindle BW, et al Pediatric Heart Network Investigators. Randomized trial of pulsed corticosteroid therapy for primary treatment of Kawasaki disease. N Engl J Med. 2007;356(7):663-675
21. Burns JC, Mason WH, Hauger SB, et al. Infliximab treatment for refractory Kawasaki syndrome. J Pediatr. 2005;146(5): 662-667 (Pubitemid 40616253)